Dr. Sanjay Chandriani serves as the VP of Translational Sciences at Trace Neuroscience, bringing expertise in molecular biology and drug development to the leadership team. With a career spanning roles at Maze Therapeutics and BioMarin Pharmaceutical, he has worked to bridge the gap between academic research and clinical application by advancing biomarker discovery and therapeutic innovation. He earned his bachelors in Biophysics at the University of Pennsylvania and his PhD in Molecular Biology from Princeton University.
